Abacus Life (NASDAQ:ABL) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.14 by 42.86 percent. The company reported quarterly sales of $28.148 million which missed the analyst consensus estimate of $28.461 million by 1.10 percent. This is a 33.27 percent increase over sales of $21.121 million the same period last year.